Работы, цитирующие эту работу

Работ: 2

Работа: IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial

1. Beyond cholesterol: targeting inflammatory biomarkers in cardiovascular disease

   Qamar Abuhassan, Tamara Nazar Saeed, Ali Fawzi Al-Hussainy +9

   СтатьяAtherosclerosis and Cardiovascular DiseasesClinica Chimica Acta2026Цитирований: 1

   ABIABI:AkademIndex/openalex/2026.article.000068

2. PCSK9 pathway-noncoding RNAs crosstalk: Emerging opportunities for novel therapeutic approaches in inflammatory atherosclerosis

   Ghaidaa Raheem Lateef Al‐Awsi, Methaq Hadi Lafta, Hamzah H. Kzar +9

   Обзорная статьяLipoproteins and Cardiovascular HealthInternational Immunopharmacology2022Цитирований: 0

   ABIABI:AkademIndex/openalex/2022.review-article.000029